GENOMIC SOLUTIONS INC
3, 2000-05-05
LABORATORY APPARATUS & FURNITURE
Previous: GENOMIC SOLUTIONS INC, 3, 2000-05-05
Next: GENOMIC SOLUTIONS INC, 3, 2000-05-05



<PAGE>   1


FORM 3



                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940


- --------------------------------------------------------------------------------
1.   Name and Address of Reporting Person(1)


Ethier                              Christine               M.
- --------------------------------------------------------------------------------
   (Last)                            (First)              (Middle)

4355 Varsity Drive Suite E
- --------------------------------------------------------------------------------
                                    (Street)

Ann Arbor                              MI                   48108
- --------------------------------------------------------------------------------
   (City)                            (State)                (Zip)

- --------------------------------------------------------------------------------
2.   Date of Event Requiring Statement (Month/Day/Year)

May 4, 2000
- --------------------------------------------------------------------------------
3.   IRS Identification Number of Reporting Person, if an Entity (Voluntary)


- --------------------------------------------------------------------------------
4.   Issuer Name and Ticker or Trading Symbol

Genomic Solutions Inc., Nasdaq National Market System, (GNSL)
- --------------------------------------------------------------------------------
5.   Relationship of Reporting Person to Issuer
               (Check all applicable)
     [_]  Director                             [_]  10% Owner
     [X]  Officer (give title below)           [_]  Other (specify below)
         Vice President of Proteomics
          --------------------------
- --------------------------------------------------------------------------------
6.   If Amendment, Date of Original (Month/Day/Year)


- --------------------------------------------------------------------------------
7.   Individual or Joint/Group Filing  (Check applicable line)

     [X]  Form Filed by One Reporting Person

     [_]  Form Filed by More Than One Reporting Person

================================================================================
             TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
================================================================================
<TABLE>
<CAPTION>
                                                                 3. Ownership Form:
                                      2. Amount of Securities       Direct (D) or
1. Title of Security                     Beneficially Owned         Indirect (I)       4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                            (Instr. 4)                 (Instr. 5)            (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
   <S>                                   <C>                         <C>                  <C>


- ------------------------------------------------------------------------------------------------------------------------------------
Callable Common Stock                         3,733                     D
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
<PAGE>   2
FORM 3 (CONTINUED)

              TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
         (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)

================================================================================
<TABLE>
<CAPTION>
                                                                                                        5. Owner-
                                                    3. Title and Amount of Securities                      ship
                                                       Underlying Derivative Securities                      Form of
                         2. Date Exercisable           (Instr. 4)                                          Derivative
                            and Expiration Date     ---------------------------------    4. Conver-        Security:
                            (Month/Day/Year)                               Amount           sion or        Direct      6. Nature of
                         ----------------------                            or               Exercise       (D) or         Indirect
                         Date       Expira-                                Number           Price of       Indirect       Beneficial
1. Title of Derivative   Exer-      tion                                   of               Derivative     (I)            Ownership
   Security (Instr. 4)   cisable    Date            Title                  Shares           Security       (Instr. 5)     (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                      <C>        <C>             <C>                    <C>           <C>            <C>            <C>


- ------------------------------------------------------------------------------------------------------------------------------------
Options                  (1)        8/24/2004       Callable Common Stock    1,667           $.07               D
- ------------------------------------------------------------------------------------------------------------------------------------
Options                  (2)        1/15/08         Callable Common Stock     600            $.37               D
- ------------------------------------------------------------------------------------------------------------------------------------
Options                  (3)        11/3/09         Callable Common Stock    39,000          $2.00              D
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Explanation of Responses:

- -------------------------
(1) These options were issued on August 24, 1997 and will vest upon completion
    of the Company's initial public offering.
(2) These options were issued on January 15, 1998 and will vest as follows: 200
    on 1/15/01; 200 on 1/15/02 and 200 on 1/15/03.
(3) These options were issued November 3, 1999 and will vest as follows: 7,800
    on 11/3/00; 7,800 on 11/3/01; 7,800 on 11/3/02; 7,800 on 11/3/03; and 7,800
    on 11/3/04.

/s/ Christine M. Ethier                                          5/4/00
- ---------------------------------------------            -----------------------
        Signature of Reporting Person(1)                          Date
             Christine M. Ethier

  (1)Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations.

     See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:  File three copies of this form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.

                                                                          Page 2

                           (Print or Type Responses)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission